Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Melanotan (MT)-II is a potent non-selective melanocortin receptor agonist with high affinity for MC1,MC3,MC4,and mc5 receptor subtypes which are involved in the regulation of a number of physiological systems such as the pigmentary system,energy homoeostasis, sexual functioning, the immune system, inflammation, and the cardiovascular system
The combination of GLP-1 therapy and renal impairment warrants closer monitoring, though these medications are generally considered safe in moderate kidney disease and some agents have shown potential renal protective benefits in clinical trials
doi:10.1681/ASN.2021050715 5
Based on simulations, the average concentration at day 10 was 66% of exposure at steady state, and the accumulation ratio was estimated to be 12.6 from day 1 to steady state (computed via simulations including inter-individual variability and inter-occasion variability)
US$ 26.27
US$ 26.26
US$ 29.71
